Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 4.650
+0.120 (2.65%)
Aug 25, 2026, 3:19 PM AEST
Artrya Revenue
In the fiscal year ending June 30, 2026, Artrya had annual revenue of 5.68M AUD with 20,167.86% growth. Artrya had revenue of 14.00K in the half year ending December 31, 2025.
Revenue
5.68M
Revenue Growth
+3.33%
P/S Ratio
26,365.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
738.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 5.68M | 5.65M | 20,167.86% |
| Jun 30, 2025 | 28.00K | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 87.98M |
| Doctor Care Anywhere Group | 75.18M |
| Alcidion Group | 51.64M |
| Mach7 Technologies | 29.70M |
| Oneview Healthcare | 21.12M |
| PharmX Technologies | 7.65M |
| Emyria | 2.29M |
| BlinkLab | 1.21M |
Artrya News
- 6 days ago - Artrya Annual report: H2 2026 - Filings
- 6 months ago - Artrya Quarterly report: H1 2026 - Filings
- 7 months ago - Artrya Earnings Call Transcript: Q2 2026 - Transcripts
- 7 months ago - Artrya Earnings release: Q2 2026 - Filings
- 9 months ago - Artrya Transcript: Bell Potter Healthcare Conference 2025 - Transcripts
- 10 months ago - Artrya Transcript: AGM 2025 - Transcripts
- 10 months ago - Artrya Slides: FY 2025 - Filings
- 10 months ago - Artrya Earnings Call Transcript: Q1 2026 - Transcripts